Drugs Made In Stock Today
| DMII Stock | 9.92 0.01 0.10% |
PerformanceFair
| Odds Of DistressLow
|
Drugs Made is trading at 9.92 as of the 11th of January 2026. This is a 0.10 percent up since the beginning of the trading day. The stock's open price was 9.91. Drugs Made has only a 7 % chance of going through financial distress over the next few years but had a somewhat fair performance during the last 90 days. The performance scores are derived for the period starting the 12th of December 2025 and ending today, the 11th of January 2026. Click here to learn more.
Business Domain Financial Services | IPO Date 3rd of December 2025 | Classification Financials |
Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange. More on Drugs Made In
Moving against Drugs Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Drugs Stock Highlights
| CEO Board | Lynn Stockwell |
| Business Concentration | Diversified Capital Markets, Financial Services, NASDAQ Composite, Financials, Capital Markets, Financial Services, Financial Services (View all Sectors) |
| Financial Strength | |
Drugs Made In (DMII) is traded on NASDAQ Exchange in USA and employs 1 people. Drugs Made is listed under Diversified Capital Markets category by Fama And French industry classification. The company conducts business under Capital Markets sector and is part of Financials industry.
Check Drugs Made Probability Of Bankruptcy
Drugs Made Historical Income Statement
Drugs Stock Against Markets
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Drugs Made In. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.